Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional study.

PROMIS-29 physical function scleroderma systemic sclerosis

Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
12 Mar 2024
Historique:
received: 24 08 2023
revised: 12 02 2024
accepted: 29 02 2024
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 12 3 2024
Statut: aheadofprint

Résumé

To compare physical function in systemic sclerosis (SSc, scleroderma) to general population normative data and identify associated factors. Scleroderma Patient-centered Intervention Network Cohort participants completed the Physical Function domain of the Patient-Reported Outcomes Measurement Information System Version 2 upon enrolment. Multivariable linear regression was used to assess associations of sociodemographic, lifestyle, and disease-related variables. Among 2,385 participants, mean physical function T-score (43.7, SD = 8.9) was ∼2/3 of a standard deviation (SD) below the US general population (mean = 50, SD = 10). Factors associated in multivariable analysis included older age (-0.74 points per SD years, 95% CI -0.78 to -1.08), female sex (-1.35, -2.37 to -0.34), fewer years of education (-0.41 points per SD in years, -0.75 to -0.07), being single, divorced, or widowed (-0.76, -1.48 to -0.03), smoking (-3.14, -4.42 to -1.85), alcohol consumption (0.79 points per SD drinks per week, 0.45-1.14), BMI (-1.41 points per SD, -1.75 to -1.07), diffuse subtype (-1.43, -2.23 to -0.62), gastrointestinal involvement (-2.58, -3.53 to -1.62), digital ulcers (-1.96, -2.94 to -0.98), moderate (-1.94, -2.94 to -0.93) and severe (-1.76, -3.24 to -0.28) small joint contractures, moderate (-2.10, -3.44 to -0.76) and severe (-2.54, -4.64 to -0.44) large joint contractures, interstitial lung disease (-1.52, -2.27 to -0.77), pulmonary arterial hypertension (-3.72, -4.91 to -2.52), rheumatoid arthritis (-2.10, -3.64 to -0.56) and idiopathic inflammatory myositis (-2.10, -3.63 to -0.56). Physical function is impaired for many individuals with SSc and associated with multiple disease factors.

Identifiants

pubmed: 38471107
pii: 7627406
doi: 10.1093/rheumatology/keae162
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Tiffany Dal Santo (T)

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Psychiatry, McGill University, Montreal, Quebec, Canada.

Danielle B Rice (DB)

Department of Psychology, St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.

Marie-Eve Carrier (ME)

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Gabrielle Virgili-Gervais (G)

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Brooke Levis (B)

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Linda Kwakkenbos (L)

Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, the Netherlands.
Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands.

Meira Golberg (M)

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Susan J Bartlett (SJ)

Department of Medicine, McGill University, Montreal, Quebec, Canada.
Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Amy Gietzen (A)

National Scleroderma Foundation, Tri-State Chapter, Buffalo, New York, USA.

Karen Gottesman (K)

National Scleroderma Foundation, Los Angeles, California, USA.

Geneviève Guillot (G)

Sclérodermie Québec, Longueuil, Quebec, Canada.

Marie Hudson (M)

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Medicine, McGill University, Montreal, Quebec, Canada.

Laura K Hummers (LK)

Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, Maryland, USA.

Vanessa L Malcarne (VL)

Department of Psychology, San Diego State University, San Diego, California, USA.
San Diego Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego, California, USA.

Maureen D Mayes (MD)

University of Texas McGovern School of Medicine, Houston, Texas, USA.

Luc Mouthon (L)

Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Paris, France.
Assistance Publique Hôpitaux de Paris-Centre, Hôpital Cochin, Université Paris Cité, Paris, France.

Michelle Richard (M)

Scleroderma Canada, Hamilton, Ontario, Canada.
Scleroderma Atlantic, Halifax, Nova Scotia, Canada.

Maureen Sauvé (M)

Scleroderma Canada, Hamilton, Ontario, Canada.
Scleroderma Society of Ontario, Hamilton, Ontario, Canada.

Robyn K Wojeck (RK)

University of Rhode Island, Kingston, Rhode Island, USA.

Marie-Claude Geoffroy (MC)

Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
, McGill Group for Suicide Studies, Douglas Research Centre, Montreal, Quebec, Canada.

Andrea Benedetti (A)

Department of Medicine, McGill University, Montreal, Quebec, Canada.
Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.

Brett D Thombs (BD)

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Department of Medicine, McGill University, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada.
Department of Psychology, McGill University, Montreal, Quebec, Canada.

Classifications MeSH